In chronic lymphocytic leukemia (CLL), PDE4 inhibition promotes apoptosis via activation of PP2A and dephosphorylation of Bcl-2 family members (48). The gene discussed is PTPA; the disease is B-cell chronic lymphocytic leukemia.